Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-13

Clinical Trial Update: ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial update for the ABLATE post-approval study investigating Synergy Ablation Lesions in persistent and longstanding persistent atrial fibrillation; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Synergy Ablation Lesions

Snippet

Sponsor: AtriCure, Inc. | Conditions: Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2019-09-13